BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21148332)

  • 1. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
    Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
    Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency.
    Gammon B; Robson A; Deonizio J; Arkin L; Guitart J
    J Am Acad Dermatol; 2014 Sep; 71(3):555-60. PubMed ID: 24813299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
    Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.
    Kasprzycka M; Zhang Q; Witkiewicz A; Marzec M; Potoczek M; Liu X; Wang HY; Milone M; Basu S; Mauger J; Choi JK; Abrams JT; Hou JS; Rook AH; Vonderheid E; Woetmann A; Odum N; Wasik MA
    J Immunol; 2008 Aug; 181(4):2506-12. PubMed ID: 18684941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
    Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
    Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
    Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
    de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
    Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
    Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma.
    Nikolova M; Echchakir H; Wechsler J; Boumsell L; Bensussan A; Bagot M
    Br J Dermatol; 2003 Jan; 148(1):24-9. PubMed ID: 12534590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
    Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Positive CD4/CD8 Primary Cutaneous Peripheral T-Cell Lymphoma Previously Classified as Mycosis Fungoides a Tumor D'Emblée.
    Raychaudhuri S; Rahvar M; Jedrych J; Karunamurthy A; Kruglov O; Rakfal S; Kane K; Akilov OE
    Am J Dermatopathol; 2018 Nov; 40(11):836-840. PubMed ID: 29794483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.
    Hamrouni A; Fogh H; Zak Z; Ødum N; Gniadecki R
    Clin Cancer Res; 2019 May; 25(10):3104-3114. PubMed ID: 30808775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.
    Delfau-Larue MH; Laroche L; Wechsler J; Lepage E; Lahet C; Asso-Bonnet M; Bagot M; Farcet JP
    Blood; 2000 Nov; 96(9):2987-92. PubMed ID: 11049975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
    Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
    J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.
    Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW
    Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.